jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

May. 20, 2015

Dec. 17, 2018

jRCT2080222857

The long term administration study of MRQ-01 in the cancer patients with breakthrough pain

version:
date:

MARUISHI PHARMACEUTICAL CO.,LTD

81-6-6962-0318

50

Interventional

Multicenter : open-label, uncontrolled

3

The cancer-related breakthrough pain which rescue needs

20age old over
No limit

Both

Cancer-related breakthrough pain

investigational material(s)
Generic name etc : MRQ-01
INN of investigational material : fentanyl
Therapeutic category code : 821 Synthetic narcotics
Dosage and Administration for Investigational material : Oral mucosa patch

Maruishi Pharmaceutical Co., Ltd.

JapicCTI-152909

History of Changes

No Publication date
10 Dec. 17, 2018 (this page) Changes
9 April. 07, 2017 Detail Changes
8 April. 07, 2017 Detail Changes
7 July. 07, 2016 Detail Changes
6 July. 07, 2016 Detail Changes
5 June. 22, 2015 Detail Changes
4 June. 22, 2015 Detail Changes
3 May. 26, 2015 Detail Changes
2 May. 20, 2015 Detail Changes
1 May. 20, 2015 Detail